Epidemiological features and dynamic changes in blood biochemical indices for COVID-19 patients in Hebi

Table 1 Clinical features of patients with coronavirus disease 2019 at admission (n = 16)

Variable
Age (yr)	34 (25, 53)
≥ 60	3 (18.7%)
50-59	2 (12.5%)
40-49	2 (12.5%)
≤ 39	9 (56.3%)
Gender
Male	7 (43.8%)
Female	9 (56.3%)
Exposure history
Living in Wuhan	7 (43.8%)
Exposure to infected patients	8 (50%)
Unknown origin	1 (6.2%)
Number of new cases
Jan 25 to Jan 31, 2020	6 (37.5%)
Feb 5 to Feb 10, 2020	10 (62.5%)
Time (d)
Interval from onset to admission	4 (2, 6)
Hospital stay	17 (14, 20)
Symptoms
Fever	13 (81.3%)
Fatigue	10 (62.5%)
Dry cough	13 (37.5%)
Cough and expectoration	13 (37.5%)
Anorexia	4 (25%)
Headache	3 (18.7%)
Pharyngalgia	2 (12.5%)
Running nose	2 (12.5%)
Chill	2 (12.5%)
Muscle soreness	2 (12.5%)
Diarrhea	1 (6.3%)
Chest distress	1 (6.3%)
Underlying disease
Hypertension	2 (12.5%)
Diabetes	2 (12.5%)
Cardiovascular disease	1 (6.3%)
Cerebrovascular disease	1 (6.3%)
Bronchitis	1 (6.3%)
Treatments
Antiviral treatment	16 (100%)
Traditional Chinese Medicine	16 (100%)
Recombinant human interferon	16 (100%)
High-flow oxygen therapy	9 (56.3%)
Anticoagulant treatment	6 (37.5%)
Digestant	5 (31.3%)
Antibiotic treatment	4 (25%)
Glucocorticoids	3 (18.7%)
Intensive care unit	2 (12.5%)
Immunoglobulin	1 (6.3%)